Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 197

Similar articles for PubMed (Select 19662924)

1.

Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management.

Holzer P, Ahmedzai SH, Niederle N, Leyendecker P, Hopp M, Bosse B, Spohr I, Reimer K.

J Opioid Manag. 2009 May-Jun;5(3):145-51. Review.

PMID:
19662924
2.

Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approach.

Reimer K, Hopp M, Zenz M, Maier C, Holzer P, Mikus G, Bosse B, Smith K, Buschmann-Kramm C, Leyendecker P.

Pharmacology. 2009;83(1):10-7. doi: 10.1159/000165778. Epub 2008 Oct 28. Review.

PMID:
18957874
3.

A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.

Meissner W, Leyendecker P, Mueller-Lissner S, Nadstawek J, Hopp M, Ruckes C, Wirz S, Fleischer W, Reimer K.

Eur J Pain. 2009 Jan;13(1):56-64. doi: 10.1016/j.ejpain.2008.06.012. Epub 2008 Aug 31.

PMID:
18762438
4.

Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.

Vondrackova D, Leyendecker P, Meissner W, Hopp M, Szombati I, Hermanns K, Ruckes C, Weber S, Grothe B, Fleischer W, Reimer K.

J Pain. 2008 Dec;9(12):1144-54. doi: 10.1016/j.jpain.2008.06.014. Epub 2008 Aug 16.

PMID:
18708300
5.

Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain - results from a large observational study.

Hermanns K, Junker U, Nolte T.

Expert Opin Pharmacother. 2012 Feb;13(3):299-311. doi: 10.1517/14656566.2012.648615. Epub 2012 Jan 6.

PMID:
22224497
6.

Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial.

Löwenstein O, Leyendecker P, Hopp M, Schutter U, Rogers PD, Uhl R, Bond S, Kremers W, Nichols T, Krain B, Reimer K.

Expert Opin Pharmacother. 2009 Mar;10(4):531-43. doi: 10.1517/14656560902796798 .

PMID:
19243306
7.

The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.

Leppert W.

Adv Ther. 2010 Oct;27(10):714-30. doi: 10.1007/s12325-010-0063-0. Epub 2010 Aug 26. Review.

PMID:
20799006
8.
9.

Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain.

Nadstawek J, Leyendecker P, Hopp M, Ruckes C, Wirz S, Fleischer W, Reimer K.

Int J Clin Pract. 2008 Aug;62(8):1159-67. doi: 10.1111/j.1742-1241.2008.01820.x.

11.
12.

Role of oxycodone and oxycodone/naloxone in cancer pain management.

Leppert W.

Pharmacol Rep. 2010 Jul-Aug;62(4):578-91. Review.

13.
14.

High doses of oxycodone-naloxone combination may provide poor analgesia.

Mercadante S, Ferrera P, Adile C.

Support Care Cancer. 2011 Sep;19(9):1471-2. doi: 10.1007/s00520-011-1205-x. Epub 2011 Jun 9.

PMID:
21656338
15.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
16.
17.

Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain.

Simpson K, Leyendecker P, Hopp M, Müller-Lissner S, Löwenstein O, De Andrés J, Troy Ferrarons J, Bosse B, Krain B, Nichols T, Kremers W, Reimer K.

Curr Med Res Opin. 2008 Dec;24(12):3503-12. doi: 10.1185/03007990802584454 .

PMID:
19032132
18.

Incidence, prevalence, and management of opioid bowel dysfunction.

Pappagallo M.

Am J Surg. 2001 Nov;182(5A Suppl):11S-18S. Review.

PMID:
11755892
19.

Innovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practice.

Schutter U, Grunert S, Meyer C, Schmidt T, Nolte T.

Curr Med Res Opin. 2010 Jun;26(6):1377-87. doi: 10.1185/03007991003787318.

PMID:
20380506
20.

Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation.

Rentz AM, Yu R, Müller-Lissner S, Leyendecker P.

J Med Econ. 2009;12(4):371-83. doi: 10.3111/13696990903430481.

PMID:
19912069
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk